Literature DB >> 30093462

Eosinophilic angiocentric fibrosis : a sino-orbital masquerader.

Nicole Legare1, Seema Frosh2, Jonathan B Vasquez3, Son T Ho4.   

Abstract

A 58-year-old Caucasian male presented with left periorbital oedema extending to the nasal area for 1 year along with nasal discharge for 1 month. Lab work was significant for positive cytoplasmic antineutrophil cytoplasmic antibodies. CT scan showed solid mass along the nasal soft tissue with bony nasal destruction. A CT scan of the thorax was performed to rule out granulomatosis with polyangiitis and showed multiple pulmonary nodules. Biopsies of the nasal mass and lung nodule were performed which showed fragments of fibrosis with spindle cell proliferation consistent with eosinophilic angiocentric fibrosis (EAF). EAF is a very rare disease, recently described as a subtype of immunoglobulin G4-related disease. A few rare cases of EAF involving the structures of the orbit have been reported in the literature. © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  ophthalmology; rheumatology

Mesh:

Substances:

Year:  2018        PMID: 30093462     DOI: 10.1136/bcr-2017-223675

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  3 in total

1.  Eosinophilic Angiocentric Fibrosis in Bilateral Upper Eyelid Conjunctivas: A First Case Report.

Authors:  Sho Okuyama; Hiroyuki Yazu; Yumi Ito; Hiroshi Minato; Hiroshi Fujishima
Journal:  Am J Case Rep       Date:  2020-05-05

2.  Eosinophilic Angiocentric Fibrosis of the Nasal Cavities: A Report of an Uncommon Lesion with Emphasis on the Etiology and Differential Diagnosis.

Authors:  Jessica Farina; Giuseppe Broggi; Carmelo Federico; Magda Zanelli; Andrea Palicelli; Rosario Caltabiano
Journal:  Medicina (Kaunas)       Date:  2022-06-28       Impact factor: 2.948

Review 3.  Eosinophilic angiocentric fibrosis of the sinonasal tract: a case report and review of the literature.

Authors:  Etrat Javadirad; Narges Eskandari Roozbahani; Sepehr Sadafi
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.